HCACR Holds Steady at 029 Hall Chadwick Acquisition Corp Rights in Tight Trading Range Star Equity Holdings STRR Holds Steady Near Support as Consolidation Continues Peabody Energy BTU Holds Steady Near MidRange After Modest Gain Bunge BG Slips Slightly as Trading Activity Reflects Cautious Sentiment Zai Lab ZLAB Slips 26 as Biotech Stocks Face Renewed Pressure STAAR Surgical STAA Gains 279 as Bullish Momentum Tests Key Resistance Zone US Payrolls Jump More Than Expected Amid Red Flags PHAR Q1 2026 Earnings EPS Misses Estimates Stock Slips NTHI Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage CBS Cancels The Late Show With Stephen Colbert Shifts LateNight Strategy With Comics Unleashed Fed Dissenters Explain Opposition to RateCut Signal Foxconn Chairman Expresses Immense Confidence in Growth Momentum Driven by AI Demand Tulsi Gabbard Resigns as Director of National Intelligence Marking Another Cabinet Departure Professional Title Okta Shares Climb After Earnings Beat and AIAgent Identity Management Outlook Iran Signals Potential Strait of Hormuz Reopening 30 Days PostPeace Deal Nikkei Reports Piper Sandler Warns Strait of Hormuz Closure Could Persist for Months Driving Oil to New Highs Standard Chartered CEO Apologizes for Lower Value Human Capital Remark Retail Sales Rise for Third Consecutive Month Signaling Steady Consumer Spending Mercurys Valuation Surges to 52 Billion as Fintech Recovery Gains Momentum Avalo Therapeutics Inc AVTX Q1 2026 Earnings NarrowerThanExpected Loss Marks Continued Progress for ClinicalStage Biotech Day One Biopharmaceuticals DAWN Holds Steady Consolidation Near Support Tests OIS Oil States delivers 245 percent Q4 2025 EPS beat shares gain 165 percent in todays trading What Investors Think About SPACSphere SSAC Stock 010 20260420 ARTCU Art Tech Acq releases no quarterly earnings details as investors await updates on planned acquisition targets Is BRC Group RILYK stock safe Q1 2024 Earnings Report Is Jena JENA stock losing technical support JENA Latest Quarter Earnings Jena posts no revenue as it seeks deSPAC targets What Dermata DRMAW flagged as biggest challenges ahead DRMAW Q3 Earnings Dermata Warrant Reports No Revenue or Earnings Data Lee LEE Stock Breakout Potential Analysis Lee misses EPS estimates by 32 amid cost pressure